Status:
COMPLETED
Iron Substitution After Upper Gastro-Intestinal Bleeding
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
GCP-unit at Aarhus University Hospital, Aarhus, Denmark
Vifor Pharma
Conditions:
Gastrointestinal Hemorrhage
Anemia
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
The trial is a double-blind randomized trial designed to examine whether compliant iron therapy (intravenous or oral) for 3 months after discharge increases hemoglobin levels more and faster than no t...
Eligibility Criteria
Inclusion
- Acute upper gastrointestinal bleeding
- Anemia
Exclusion
- Liver disease
- Terminal cancer
- Kidney disease
- variceal bleeding
- Pregnancy
Key Trial Info
Start Date :
April 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
97 Patients enrolled
Trial Details
Trial ID
NCT00978575
Start Date
April 1 2010
End Date
April 1 2013
Last Update
April 5 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aarhus University Hospital
Aarhus, Aarhus, Denmark, 8000